Skip to main content
Log in

Diabetes mellitus as presenting feature in extra-adrenal pheochromocytoma: Report of a case

  • Case Report
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

Secondary diabetes mellitus was the main abnormal finding in a young lean woman with benign extra-adrenal para-aortic norepinephrine and dopamine secreting pheochromocytoma. Glucose and insulin response to oral glucose and C-peptide secretion after glucagon i.v. were evaluated before and after alpha-blockade with phenoxybenzamine. Alpha-blocking treatment restored the inhibited basal and stimulated C-secretion but did not normalize glucose tolerance. After tumor removal metabolic abnormalities were normalized, confirming the role of endogenous catecholamine excess in the pathogenesis of our patient’s glucose intolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beschi M., Castellano M., Agabiti-Rosei E., Rossini P., Muiesan G.: Assessment of semi-automated catecholamine assay by HPLC: choice of reverse phase C-18 or cation-exchange columns — Chromatographia24, 455–459, 1987.

    CAS  Google Scholar 

  2. Bravo E. M., Gifford R. W. Jr.: Pheochromocytoma: diagnosis, localization and management — New Engl. J. Med.311, 1298–1303, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Colwell J. A.: Inhibition of insulin secretion by catecholamines in pheochromocytoma — Ann. intern. med.71, 251–256, 1969.

    PubMed  CAS  Google Scholar 

  4. Cryer P. E.: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system — New Engl. J. Med.303, 436–444, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Cryer P. E.: Pheochromocytoma — J. clin. Endocrinol. Metabol.14, 203–220, 1985.

    Article  CAS  Google Scholar 

  6. Elliott W. J., Murphy M. B., Straus F. H., Jarabak J.: Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade — Arch. intern. Med.149, 214–216, 1989.

    Article  PubMed  CAS  Google Scholar 

  7. Lorenzi M., Karan J. E., Tsalikian E., Bohannon N. V., Gerich J. E., Forsham P. H.: Dopamine during alpha or beta adrenergic blockade in man — J. clin. Invest.63, 310–317, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. Quickel K. E. Jr., Feldman J. M., Lebovitz H. E.: Inhibition of insulin secretion by serotonin and dopamine species variation — Endocrinology89, 1295–1302, 1971.

    PubMed  CAS  Google Scholar 

  9. Turnbull D. M., Johnson D. G., Alberti K. G. M. M., Hall R.: Hormonal and metabolic studies in a patient with a pheochromocytoma — J. clin. Endocrinol. Metabol.51, 930–933, 1979.

    Article  Google Scholar 

  10. Vance J. E., Buchanan K. D., O’Hara D., Williams R. H., Porte D. Jr: Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha-adrenergic blockade — Ann. intern. Med.71, 251–256, 1969.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balestrieri, P.G., Spandrio, S., Romanelli, G. et al. Diabetes mellitus as presenting feature in extra-adrenal pheochromocytoma: Report of a case. Acta diabet. lat 27, 261–265 (1990). https://doi.org/10.1007/BF02581338

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02581338

Key-words

Navigation